Tobacco stocks drop as FDA probes possible link between seizures and vaping

By | April 3, 2019

Tobacco stocks dipped Wednesday after the Food and Drug Administration said it was investigating nearly three dozen cases of people who had seizures after vaping.

Altria, which late last year invested $ 12.8 billion for a 35 percent stake in e-cigarette giant Juul, fell by more than 3 percent. Shares of British American Tobacco traded in the U.S. slid 1.6 percent. Shares of U.K.-based Imperial Brands traded in the U.S. dipped 2.7 percent.

Even though the FDA didn’t directly blame e-cigarettes, the news won’t help the already negative perception surrounding the devices. A study published last week from researchers at Georgia State University found the proportion of adults who think e-cigarettes are as bad as or worse than combustible cigarettes increased substantially over five years.

The news may also spook investors who are already fearing the FDA will tighten e-cigarette restrictions even more as it tries to control what the agency has labeled an “epidemic” of teen vaping.

For more on investing in health care innovation, click here to join CNBC at our Healthy Returns Summit in New York City on May 21.

Health and Science

Read More:  FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy